Editorial
doi: 10.1212/01.wnl.0000324860.70391.25.
Agonist or levodopa for Parkinson disease?: ultimately, it doesn't matter; neither is good enough
- PMID: 18695156
- DOI: 10.1212/01.wnl.0000324860.70391.25
Item in Clipboard
Editorial
Agonist or levodopa for Parkinson disease?: ultimately, it doesn't matter; neither is good enough
Neurology.
.
No abstract available
Comment in
-
Agonist or levodopa for Parkinson disease? Ultimately, it doesn't matter; neither is good enough.Neurology. 2009 Jun 16;72(24):2137; author reply 2137-8. doi: 10.1212/01.wnl.0000349695.96741.88. Neurology. 2009. PMID: 19528526 No abstract available.
Comment on
-
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD.Neurology. 2008 Aug 12;71(7):474-80. doi: 10.1212/01.wnl.0000310812.43352.66. Epub 2008 Jun 25. Neurology. 2008. PMID: 18579806 Clinical Trial.
Similar articles
-
Agonist or levodopa for Parkinson disease? Ultimately, it doesn't matter; neither is good enough.Neurology. 2009 Jun 16;72(24):2137; author reply 2137-8. doi: 10.1212/01.wnl.0000349695.96741.88. Neurology. 2009. PMID: 19528526 No abstract available.
-
Levodopa: management of Parkinson's disease.Mov Disord. 2002;17 Suppl 4:S23-37. doi: 10.1002/mds.5558. Mov Disord. 2002. PMID: 12211137 Review. No abstract available.
-
Parkinson's disease.Am Fam Physician. 2007 Apr 1;75(7):1045-8. Am Fam Physician. 2007. PMID: 17427619 No abstract available.
-
[Modification of Parkinson tremor by budipine. A comparative study with amantadine].Nervenarzt. 1986 Mar;57(3):184-6. Nervenarzt. 1986. PMID: 3515215 Clinical Trial. German. No abstract available.
-
Levodopa therapeutics for Parkinson's disease: new developments.Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S31-4. doi: 10.1016/S1353-8020(09)70009-4. Parkinsonism Relat Disord. 2009. PMID: 19131040 Review.
Cited by
-
Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist.Curr Neuropharmacol. 2016;14(4):356-63. doi: 10.2174/1570159x14666151208114634. Curr Neuropharmacol. 2016. PMID: 26644151 Free PMC article. Review.
-
Protective effects of SKF-96365, a non-specific inhibitor of SOCE, against MPP+-induced cytotoxicity in PC12 cells: potential role of Homer1.PLoS One. 2013;8(1):e55601. doi: 10.1371/journal.pone.0055601. Epub 2013 Jan 31. PLoS One. 2013. PMID: 23383239 Free PMC article.
-
Improving symptom control in early Parkinson's disease.Ther Adv Neurol Disord. 2009 Nov;2(6):29-41. doi: 10.1177/1756285609339383. Ther Adv Neurol Disord. 2009. PMID: 21180628 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
